Julien Bailes, MD

Chief Medical Officer of CereMark Pharma

Articles by Julien Bailes, MD

New CTE Prevalence Estimate Underscores Push for Diagnosis Living Patients

ByLouie Pasculli,Rory Siegel, DO,Julien Bailes, MD

November 10th 2026

A study of deceased former NFL players estimated that nearly 75% had CTE neuropathology, while a phase 3 trial is evaluating whether F-18 FNT-PET imaging could help identify disease-associated patterns in living patients.

Julien Bailes, MD

Articles by Julien Bailes, MD

New CTE Prevalence Estimate Underscores Push for Diagnosis Living Patients

Latest Updated Articles

Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights

FDA Approves Factor XIa Inhibitor Asundexian for Secondary Stroke Prevention

FDA Investigates Confirmed Insertional Oncogenesis With Spinal Muscular Atrophy Gene Therapy

Identifying the Biggest Neuromuscular Advocacy Challenges for 2027: Paul Melmeyer, MPP

Understanding the Role of TAPS Therapy in Essential Tremor Management: Stuart H. Isaacson, MD, FAAN

Consistent TAPS Use Associated With Underlying Tremor Improvement in Essential Tremor